Hot Pursuit     29-May-24
Eureka Forbes records over 31% YoY jump in Q4 PAT; EBITDA margin at 9.5%
Eureka Forbes has reported 31.1% rise in net profit to Rs 21.4 crore on a 8.8% increase in revenue to Rs 553.1 crore in Q4 FY24 as compared with Q4 FY23.

Total expenses rose by 3.1% year-over-year (YoY) to Rs 264.3 crore during the quarter, due to higher employee expenses (up 22% YoY) and higher service charges (up 3.1% YoY). This was offset to some extent by lower other expenses (down 6.8% YoY).

EBITDA improved by 11.1% to Rs 52.7 crore in Q4 FY24 from Rs 47.4 crore in Q4 FY23. EBITDA margin was 9.5% in Q4 FY24 as against 9.3% in Q4 FY23.

Profit before tax in Q4 FY24 stood at Rs 24.2 crore, down by 6.3% from Rs 25.8 crore in Q4 FY23.

For FY24, Eureka Forbes has reported net profit and revenue of Rs 91.5 crore (up 5.4x YoY) and Rs 2,189.2 crore (up 5.2% YoY), respectively.

Pratik Pota, MD, and CEO, Eureka Forbes, said: "As we exit the first full year of our transformation program Udaan, I am pleased to report progress on multiple fronts.

Continuing businesses grew by 11.4% in Q4 and by 7.9% for the year with H2 growth of 14.0%.

Driven by operating efficiencies and leverage, EBITDA margins for Q4 reached a lifetime high of 11.2% - an improvement of 186bps year on year.

For the FY, EBITDA margins expanded by 401bps to 10.3% in FY24 with a full year operational cash flow generation of Rs 194Cr.

Transformation initiatives gathered momentum with the most visible impact in the areas of product innovations and consumer campaigns. Several new and industry first products were launched in all 3 categories of Electric Water Purifiers, Vacuum Cleaners and Air Purifiers. New launches were backed with advertising campaigns focused on driving penetration and category adoption.

The progress we have achieved in the first year of our transformation and with momentum of a double-digit H2 growth and lifetime high margins in Q4 give us the confidence and the energy as we enter the next stage in this journey of transforming this iconic brand and Company to its rightful place.”

Eureka Forbes is India’s leading health and hygiene brand. With over four decades of existence, it is today a multi-product and an omni-channel organization. Eureka Forbes’ product portfolio encompasses water purification, vacuum cleaning and air purification. It has direct, retail, e-commerce and institutional sales channels, an inventive business partner network and one of the most expansive service networks across India.

The scrip rose 1% to end at Rs 434.30 on the BSE today.

Previous News
  Eureka Forbes reports consolidated net profit of Rs 6.88 crore in the December 2022 quarter
 ( Results - Announcements 15-Feb-23   08:01 )
  Board of Eureka Forbes accepts resignation of MD cum CEO
 ( Corporate News - 20-Jun-22   19:42 )
  Marzin R. Shroff resigns as MD and CEO of Eureka Forbes
 ( Corporate News - 21-Jun-22   09:42 )
  Eureka Forbes records over 31% YoY jump in Q4 PAT; EBITDA margin at 9.5%
 ( Hot Pursuit - 29-May-24   17:24 )
  Eureka Forbes' MD and CEO resigns
 ( Hot Pursuit - 21-Jun-22   13:06 )
  Eureka Forbes to conduct AGM
 ( Corporate News - 26-Aug-23   12:05 )
  Eureka Forbes reports consolidated net loss of Rs 20.75 crore in the September 2022 quarter
 ( Results - Announcements 15-Nov-22   08:39 )
  Marzin Shroff resigns as Eureka Forbes MD & CEO
 ( Corporate News - 12-Jul-22   17:04 )
  Eureka Forbes spurts as Q4 PAT soars 98% YoY
 ( Hot Pursuit - 30-May-23   12:23 )
  Eureka Forbes to hold board meeting
 ( Corporate News - 09-Feb-24   12:37 )
  Eureka Forbes appoints Pratik Pota as MD & CEO
 ( Corporate News - 12-Jul-22   17:06 )
Other Stories
  Marico's domestic biz sees modest volume growth in Q1
  06-Jul-24   12:25
  Titan revenue rises 9% YoY, adds 61 stores in Q1
  06-Jul-24   11:09
  Dabur India expects mid to high digit revenue growth in Q1
  06-Jul-24   10:40
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
  Utkarsh SFB deposits climb 30% YoY in Q1 FY25
  05-Jul-24   14:35
Back Top